In2Bones Gains FDA Clearance for Quantum Total Ankle
The clearance marks the company’s entrance into the total ankle replacement market and complements its products for upper and lower...
Feb 07 2020,
Products
RSIP Vision: Company to Watch in Surgical Planning
RSIP Vision has taken additional steps to apply its technologies to the planning of hip and shoulder replacement....
Feb 07 2020,
Year in Review: Orthopedic Companies with First U.S. Products
One of our favorite lists that we compile every year is newer companies that hit our radar. This review pinpoints...
Jan 21 2020,
FDA 510(k) Recap: 9 First Clearances and Line Extensions
This month’s recap highlights devices of interest that received first clearances from companies new on our radar, like Augmedics, Avanti...
Jan 21 2020,
Silver Bullet Therapeutics Gains CE Mark for OrthoFuzIon Bone Screw
An expanded CE Mark positions the company to improve patient care in the EU, and potentially disrupt the established commercial...
Jan 20 2020,
Augmedics Launches xvision AR Surgical Guidance
The augmented reality system allows surgeons to visualize anatomy in real time, as if using x-ray vision, to guide instruments...
Jan 06 2020,
6 Orthobiologic Companies Move Clinical Trials Forward
Multiple orthobiologic companies have engaged in clinical trials in 2019, seeking to demonstrate the efficacy of their cell-based products. We've...
Dec 12 2019,
Smith+Nephew Announces First JOURNEY II Unicompartmental Knee Procedures
The JOURNEY II Uni Knee is designed to bring the natural feel of JOURNEY II to partial knee arthroplasty patients...
Dec 10 2019,
Empirical Spine Completes Portion of Enrollment for LimiFlex Clinical Trial
Enrollment is complete in the investigational arm of the U.S. IDE trial of the LimiFlex Paraspinous Tension Band with decompression....
Dec 10 2019,
ulrich medical USA Launches Momentum Posterior Spinal Fixation
Momentum is compatible with the company's neon3 Universal OCT Spinal Stabilization System, which launched in 2012....
Dec 10 2019,
Executive Interview: Carmell Therapeutics on its Controlled Degradable Biologic
Carmell Therapeutics' proprietary process binds and cross-links regenerative factors in lyophilized platelet-enriched plasma into solid and semi-solid plasma-based materials to...
Dec 10 2019,
4 New Technologies in Spine, Joint Replacement, Trauma, Sports Medicine
Small and mid-sized orthopedic companies bolstered their portfolios at year-end with products to help grow revenue in the coming year....
Dec 03 2019,
Lack of Clinical Evidence Leaves Questions about Orthobiologic Development and Promotion
In the race to capitalize on patient-driven interest in stem cells, biologic and regenerative solutions, there has been an explosion...
Dec 02 2019,
Knee and Spine Osteoarthritis Ripe Areas for New Orthobiologic Products
Dr. Steven Sampson, Founder of the well-known TOBI Symposium, shares his take on the state of regenerative medicine and the...
Dec 02 2019,
FDA 510(k) Review: 2019 Additively-Manufactured Product Clearances
Spine implants accounted for the majority of the additive manufactured products that received FDA 510(k) clearance in 2019. Our review...
Dec 02 2019,